{"id":70,"date":"2020-04-30T11:14:00","date_gmt":"2020-04-30T10:14:00","guid":{"rendered":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/2020\/04\/30\/hope-for-treatment-remdesivir-revisited\/"},"modified":"2021-03-24T09:29:40","modified_gmt":"2021-03-24T09:29:40","slug":"hope-for-treatment-remdesivir-revisited","status":"publish","type":"post","link":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/2020\/04\/30\/hope-for-treatment-remdesivir-revisited\/","title":{"rendered":"Hope for treatment? Remdesivir revisited."},"content":{"rendered":"<p><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\">I posted regarding Remdesivir, an anti-viral drug which had showed early<a href=\"https:\/\/www.ctu.mrc.ac.uk\/news\/news-stories\/2020\/april\/actt-euuk-trial-finds-remdesivir-speeds-up-covid-19-recovery\/\">&nbsp;promising effects&nbsp;<\/a>for COVID. This showed shortening of the recovery time from 15 to 11 days and a reduction in mortality from 11 to 8%. So, any talk of a &#8216;cure&#8217; is mis-placed, hopefully it might help.<\/span><br \/><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\"><br \/><\/span><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\">Unfortunately, it showed no benefit in a subsequent trial in China. This was inadvertently posted by the WHO, noticed by the worlds press, and then quickly removed for peer review. Now it&#8217;s been&nbsp;<a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736%2820%2931022-9\/fulltext\">published in the Lancet.<\/a>&nbsp;<\/span><\/p>\n<p> <span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\">Today I read that hopes<a href=\"https:\/\/www.nih.gov\/news-events\/news-releases\/nih-clinical-trial-remdesivir-treat-covid-19-begins\">&nbsp;for this treatment are alive and well<\/a>, at least for the moment.&nbsp;It seems that Gilead are now pressing ahead with larger longer trials of the intravenous drug and for better end-points. The results will be eagerly awaited. &nbsp;<\/span><br \/><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\"><br \/><\/span><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\">It may be that Remdesivir will find a role, perhaps even in combination with other drugs as the results of trials come in. COVID science is moving along at an incredible pace. Patients and patience are needed.<\/span><br \/><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\"><br \/><\/span><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\">One&nbsp;disadvantage&nbsp;is that&nbsp;it&#8217;s&nbsp;an intravenous drug with implications for its use and availability for most of the world, las well as its cost.&nbsp;<\/span><br \/><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\"><br \/><\/span><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\">The other issue is whether, like many anti virals (and MS drugs) it will be more&nbsp;effective&nbsp;if administered &nbsp;early and to at-risk patients with milder illness.&nbsp;Personally&nbsp;I think this likely to be the case but makes the issues of administration and cost loom larger still.<\/span><br \/><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\"><br \/><\/span><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\">In any case, until the trial results roll in, hope springs eternal.&nbsp;<\/span><br \/><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\"><br \/><\/span><span style=\"font-family: &quot;arial&quot; , &quot;helvetica&quot; , sans-serif;\">Watch this space!<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>I posted regarding Remdesivir, an anti-viral drug which had showed early&nbsp;promising effects&nbsp;for COVID. This showed&hellip; <a href=\"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/2020\/04\/30\/hope-for-treatment-remdesivir-revisited\/\" class=\"more-link btn btn-link\">Read More&hellip; <span class=\"screen-reader-text\">Continue reading Hope for treatment? Remdesivir revisited.<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","footnotes":""},"categories":[21],"tags":[],"class_list":["post-70","post","type-post","status-publish","format-standard","hentry","category-pandemic-management"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/wp-json\/wp\/v2\/posts\/70","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/wp-json\/wp\/v2\/comments?post=70"}],"version-history":[{"count":1,"href":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/wp-json\/wp\/v2\/posts\/70\/revisions"}],"predecessor-version":[{"id":660,"href":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/wp-json\/wp\/v2\/posts\/70\/revisions\/660"}],"wp:attachment":[{"href":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/wp-json\/wp\/v2\/media?parent=70"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/wp-json\/wp\/v2\/categories?post=70"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drbannonsblog.aprendo.co.uk\/drbannonsblog_wp\/wp-json\/wp\/v2\/tags?post=70"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}